Controlled release of liraglutide using thermogelling polymers in treatment of diabetes

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chen, Yipei ^a   Li, Yuzhuo ^a   Shen, Wenjia ^a   Li, Kun ^b   Yu, Lin ^a   Chen, Qinghua ^b   Ding, Jiandong ^a  

^a FUDAN UNIVERSITY   (China)

^b National Pharmaceutical Engineering Research Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; LIRAGLUTIDE; POLYMER;

ANIMAL; GEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GELS; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; LIRAGLUTIDE; MICE; MICE, INBRED ICR; POLYMERS;

EID: 84982175120     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31593     Document Type: Article

References (64)

1. Drucker, D. J. & Nauck, M. A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696-1705 (2006).
2. Tahrani, A. A., Piya, M. K., Kennedy, A. & Barnett, A. H. Glycaemic control in type 2 diabetes: Targets and new therapies. Pharmacol. Ther. 125, 328-361 (2010).
3. Kim, P. H., Lee, M. & Kim, S. W. Delivery of two-step transcription amplification exendin-4 plasmid system with arginine-grafted bioreducible polymer in type 2 diabetes animal model. J. Control. Release 162, 9-18 (2012).
4. Doyle, M. E. & Egan, J. M. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol. Ther. 113, 546-593 (2007).
5. Ryan, G. J., Foster, K. T. & Jobe, L. J. Review of the therapeutic uses of liraglutide. Clin. Ther. 33, 793-811 (2011).
6. Montanya, E. & Sesti, G. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus. Clin. Ther. 31, 2472-2488 (2009).
7. Mari, A. et al. Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on beta-cell function in normal living conditions. Diabetes Care 30, 2032-2033 (2007).
8. Jelsing, J. et al. Liraglutide: short-lived effect on gastric emptyingulong lasting effects on body weight. Diabetes Obes. Metab. 14, 531-538 (2012).
9. Vilsboll, T. et al. Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes. Diabetes Care 30, 1608-1610 (2007).
10. Jeong, B., Bae, Y. H., Lee, D. S. & Kim, S. W. Biodegradable block copolymers as injectable drug-delivery systems. Nature 388, 860-862 (1997).
11. Park, M. H., Joo, M. K., Choi, B. G. & Jeong, B. Biodegradable thermogels. Acc. Chem. Res. 45, 424-433 (2012).
12. Shi, K. et al. Synthesis, characterization, and application of reversible PDLLA-PEG-PDLLA copolymer thermogels in vitro and in vivo. Sci Rep 6, 19077 (2016).
13. Yang, Y. et al. A novel gene delivery composite system based on biodegradable folate-poly (ester amine) polymer and thermosensitive hydrogel for sustained gene release. Sci Rep 6, 21402 (2016).
14. Yu, L. & Ding, J. D. Injectable hydrogels as unique biomedical materials. Chem. Soc. Rev. 37, 1473-1481 (2008).
15. Chen, S. et al. Mesenchymal stem cell-laden anti-inflammatory hydrogel enhances diabetic wound healing. Sci Rep 5, 18104 (2015).
16. Wang, W. et al. Dual-functional transdermal drug delivery system with controllable drug loading based on thermosensitive poloxamer hydrogel for atopic dermatitis treatment. Sci Rep 6, 24112 (2016).
17. Vermonden, T., Censi, R. & Hennink, W. E. Hydrogels for protein delivery. Chem. Rev. 112, 2853-2888 (2012).
18. Kwon, J. S. et al. Injectable in situ-forming hydrogel for cartilage tissue engineering. J. Mater. Chem. B 1, 3314-3321 (2013).
19. Moon, H. J., Patel, M., Chung, H. & Jeong, B. Nanocomposite versus mesocomposite for osteogenic differentiation of tonsil-derived mesenchymal stem cells. Adv. Healthc. Mater. 5, 353-363 (2016).
20. Jeong, Y. et al. Enzymatically degradable temperature-sensitive polypeptide as a new in-situ gelling biomaterial. J. Control. Release 137, 25-30 (2009).
21. Tirella, A. et al. Nano-in-micro self-reporting hydrogel constructs. J. Biomed. Nanotechnol. 11, 1451-1460 (2015).
22. Fan, M. et al. Dexamethasone-loaded poly(D, L-lactic acid) microspheres/poly(ethylene glycol)-poly(epsilon-caprolactone)- poly(ethylene glycol) micelles composite for skin augmentation. J. Biomed. Nanotechnol. 10, 592-602 (2014).
23. Fu, S. Z. et al. Biodegradable and thermosensitive monomethoxy poly(ethylene glycol)-poly(lactic acid) hydrogel as a barrier for prevention of post-operative abdominal adhesion. J. Biomed. Nanotechnol. 10, 427-435 (2014).
24. Song, F. F., Li, X. Q., Wang, Q., Liao, L. Q. & Zhang, C. Nanocomposite hydrogels and their applications in drug delivery and tissue engineering. J. Biomed. Nanotechnol. 11, 40-52 (2015).
25. Shim, M. S. et al. Poly(D, L-lactic acid-co-glycolic acid)-b-poly(ethylene glycol)-b-poly (D, L-lactic acid-co-glycolic acid) triblock copolymer and thermoreversible phase transition in water. J. Biomed. Mater. Res. 61, 188-196 (2002).
26. Yu, L., Zhang, H. & Ding, J. D. A subtle end-group effect on macroscopic physical gelation of triblock copolymer aqueous solutions. Angew. Chem. Int. Ed. 45, 2232-2235 (2006).
27. Yu, L., Zhang, Z., Zhang, H. & Ding, J. D. Mixing a sol and a precipitate of block copolymers with different block ratios leads to an injectable hydrogel. Biomacromolecules 10, 1547-1553 (2009).
28. Yu, L., Zhang, Z. & Ding, J. D. Influence of LA and GA sequence in the PLGA block on the properties of thermogelling PLGA-PEGPLGA block copolymers. Biomacromolecules 12, 1290-1297 (2011).
29. He, C. L., Zhuang, X. L., Tang, Z. H., Tian, H. Y. & Chen, X. S. Stimuli-sensitive synthetic polypeptide-based materials for drug and gene delivery. Adv. Healthc. Mater. 1, 48-78 (2012).
30. Park, M. H. et al. 3D culture of tonsil-derived mesenchymal stem cells in poly(ethylene glycol)-poly(L-alanine-co-L-phenyl alanine) thermogel. Adv. Healthc. Mater. 3, 1782-1791 (2014).
31. Park, M. R. et al. Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel. J. Control. Release 147, 359-367 (2010).
32. Seo, B. B., Choi, H., Koh, J. T. & Song, S. C. Sustained BMP-2 delivery and injectable bone regeneration using thermosensitive polymeric nanoparticle hydrogel bearing dual interactions with BMP-2. J. Control. Release 209, 67-76 (2015).
33. Zentner, G. M. et al. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J. Control. Release 72, 203-215 (2001).
34. Yu, L., Zhang, Z., Zhang, H. & Ding, J. D. Biodegradability and biocompatibility of thermoreversible hydrogels formed from mixing a sol and a precipitate of block copolymers in water. Biomacromolecules 11, 2169-2178 (2010).
35. Yu, L., Sheng, W. J., Yang, D. C. & Ding, J. D. Design of molecular parameters to achieve block copolymers with a powder form at dry state and a temperature-induced sol-gel transition in water without unexpected gelling prior to heating. Macromol. Res. 21, 207-215 (2013).
36. Chen, L., Ci, T. Y., Li, T., Yu, L. & Ding, J. D. Effects of molecular weight distribution of amphiphilic block copolymers on their solubility, micellization, and temperature-induced sol gel Transition in water. Macromolecules 47, 5895-5903 (2014).
37. Lei, K. W., Shen, W. J., Cao, L. P., Yu, L. & Ding, J. D. An injectable thermogel with high radiopacity. Chem. Commun. 51, 6080-6083 (2015).
38. Petit, A. et al. Effect of polymer composition on rheological and degradation properties of temperature-responsive gelling systems composed of acyl-capped PCLA-PEG-PCLA. Biomacromolecules 14, 3172-3182 (2013).
39. Yu, L., Chang, G. T., Zhang, H. & Ding, J. D. Temperature-induced spontaneous sol-gel transitions of poly(D, L-lactic acid-coglycolic acid)-b-poly(ethylene glycol)-b-poly(D, L-lactic acid-co-glycolic acid) triblock copolymers and their end-capped derivatives in water. J. Polym. Sci., Part A: Polym. Chem. 45, 1122-1133 (2007).
40. Ma, H. C. et al. Localized co-delivery of doxorubicin, cisplatin, and methotrexate by thermosensitive hydrogels for enhanced osteosarcoma treatment. ACS Appl. Mater. Interfaces 7, 27040-27048 (2015).
41. Li, K. et al. A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel. Biomaterials 34, 2834-2842 (2013).
42. Ci, T. Y., Chen, L., Yu, L. & Ding, J. D. Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel. Sci Rep 4, 5473 (2014).
43. Ni, P. et al. Injectable thermosensitive PEG-PCL-PEG hydrogel/acellular bone matrix composite for bone regeneration in cranial defects. Biomaterials 35, 236-248 (2014).
44. Chen, L. et al. An injectable hydrogel with or without drugs for prevention of epidural scar adhesion after laminectomy in rats. Chin. J. Polym. Sci. 34, 147-163 (2016).
45. Wu, Q. J. et al. Thermosensitive hydrogel containing dexamethasone micelles for preventing postsurgical adhesion in a repeatedinjury model. Sci Rep 5, 13553 (2015).
46. Zhang, Z. et al. Biodegradable and thermoreversible PCLA-PEG-PCLA hydrogel as a barrier for prevention of post-operative adhesion. Biomaterials 32, 4725-4736 (2011).
47. Cao, L. et al. Safe and efficient colonic endoscopic submucosal dissection using an injectable hydrogel. ACS Biomater. Sci. Eng. 2, 393-402 (2016).
48. Tang, Y. & Singh, J. Biodegradable and biocompatible thermosensitive polymer based injectable implant for controlled release of protein. Int. J. Pharm. 365, 34-43 (2009).
49. Yu, L. et al. In vitro and in vivo evaluation of a once-weekly formulation of an antidiabetic peptide drug exenatide in an injectable thermogel. J. Pharm. Sci. 102, 4140-4149 (2013).
50. Petit, A. et al. Release behavior and intra-articular biocompatibility of celecoxib-loaded acetyl-capped PCLA-PEG-PCLA thermogels. Biomaterials 35, 7919-7928 (2014).
51. Pitt, C. G., Jeffcoat, A. R., Zweidinger, R. A. & Schindler, A. Sustained drug delivery systems.1. permeability of poly(epsiloncaprolactone), poly(DL-lactic acid), and their copolymers. J. Biomed. Mater. Res. 13, 497-507 (1979).
52. Pitt, C. G., Gratzl, M. M., Jeffcoat, A. R., Zweidinger, R. & Schindler, A. Sustained drug delivery systems. 2. factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. J. Pharm. Sci. 68, 1534-1538 (1979).
53. Sinha, V. R., Bansal, K., Kaushik, R., Kumria, R. & Trehan, A. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 278, 1-23 (2004).
54. Lemoine, D. et al. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D, L-lactide) and poly(D, L-lactideco- glycolide). Biomaterials 17, 2191-2197 (1996).
55. Cao, L. P. et al. An injectable hydrogel formed by in situ cross-linking of glycol chitosan and multi-benzaldehyde functionalized PEG analogues for cartilage tissue engineering. J. Mater. Chem. B 3, 1268-1280 (2015).
56. Chuang, E. Y. et al. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats. J. Control. Release 172, 513-522 (2013).
57. Jeong, B., Lee, K. M., Gutowska, A. & An, Y. H. H. Thermogelling biodegradable copolymer aqueous solutions for injectable protein delivery and tissue engineering. Biomacromolecules 3, 865-868 (2002).
58. Choi, S., Baudys, M. & Kim, S. W. Control of blood glucose by novel GLP-1 delivery using biodegradable triblock copolymer of PLGA-PEG-PLGA in type 2 diabetic rats. Pharm. Res. 21, 827-831 (2004).
59. Choi, S. & Kim, S. W. Controlled release of insulin from injectable biodegradable triblock copolymer depot in ZDF rats. Pharm. Res. 20, 2008-2010 (2003).
60. Ge, H. X., Hu, Y., Yang, S. C., Jiang, X. Q. & Yang, C. Z. Preparation, characterization, and drug release behaviors of drug-loaded epsilon-caprolactone/L-lactide copolymer nanoparticles. J. Appl. Polym. Sci. 75, 874-882 (2000).
61. Jiao, Y. Y. et al. Preparation and characterization of heparin-loaded polymeric microparticles. Drug Dev. Ind. Pharm. 28, 1033-1041 (2002).
62. Dash, T. K. & Konkimalla, V. B. Poly-epsilon-caprolactone based formulations for drug delivery and tissue engineering: A review. J. Control. Release 158, 15-33 (2012).
63. Cha, Y. & Pitt, C. G. A one-week subdermal delivery system for L-methadone based on biodegradable microcapsules. J. Control. Release 7, 69-78 (1988).
64. McDonald, P. F., Lyons, J. G., Geever, L. M. & Higginbotham, C. L. In vitro degradation and drug release from polymer blends based on poly(DL-lactide), poly(L-lactide-glycolide) and poly(epsilon-caprolactone). J. Mater. Sci. 45, 1284-1292 (2010).